948 Results

People

  1. Kris
    Kris
  2. Kelsen
    Kelsen
  3. Motzer
    Motzer
  4. O'Reilly
    O'Reilly
  5. Saltz
    Saltz
  6. Tyson
    Tyson
  7. Gralla
    Gralla
  8. Hudis
    Hudis
  9. Scher
    Scher
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)
  7. Center for Hematologic Malignancies (109)
  8. Genitourinary Oncology Service (106)
  9. Nursing (101)
  10. Surgery (97)
  1. "vomiting"
Formats
  1. Journal Article (896)
  2. Review (27)
  3. Conference Paper (8)
  4. Editorial (6)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Book Section (1)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)

More Groups

People
  1. Mark Kris (70)
  2. David Kelsen (40)
  3. Robert Motzer (39)
  4. Eileen O'Reilly (30)
  5. Leonard Saltz (30)
  6. Leslie Tyson (28)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (44)
  4. 2022 (32)
  5. 2021 (15)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Cancer (47)
  3. Clinical Cancer Research (44)
  4. Lancet Oncology (38)
  5. Gynecologic Oncology (31)
  6. Cancer Treatment Reports (26)

More Publications

Publishers
  1. Elsevier Inc. (145)
  2. American Society of Clinical Oncology (92)
  3. Elsevier Science, Inc. (74)
  4. Springer (72)
  5. Oxford University Press (64)
  6. Wiley Blackwell (63)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study
    Journal Article

    Nooka, A. K.; Kaufman, J. L.; Rodriguez, C.; Jakubowiak, A.; Efebera, Y.; Reeves, B.; Wildes, T. M.; Holstein, S. A.; Anderson, L. D. Jr; Badros, A.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Journal Article

    Makker, V.; Perez-Fidalgo, J. A.; Valabrega, G.; Hamilton, E.; Van Gorp, T.; Sehouli, J.; Regináčová, K.; Richardson, D. L.; Perri, T.; Oza, A. M.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A plain language summary of the PHAROS study: The combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer
    Review

    Riely, G. J.; Smit, E. F.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Tsao, A.; Johnson, M.; Gelsomino, F.; Esper, R.; Nadal, E.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • An open-label study of pemigatinib in cholangiocarcinoma: Final results from FIGHT-202
    Journal Article

    Vogel, A.; Sahai, V.; Hollebecque, A.; Vaccaro, G. M.; Melisi, D.; Al Rajabi, R. M.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial
    Journal Article

    Lim, S. H.; Saluja, A.; Vickers, S.; Hong, J. Y.; Kim, S. T.; Lavania, S.; Pandey, S.; Gupta, V. K.; Velagapudi, M. R.; Lee, J.
    Cancer Letters (2024)

    Fulltext@MSK | Save
  • CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: Results of two multi-institutional Phase 1 trials
    Journal Article

    Segal, N. H.; Melero, I.; Moreno, V.; Steeghs, N.; Marabelle, A.; Rohrberg, K.; Rodriguez-Ruiz, M. E.; Eder, J. P.; Eng, C.; Manji, G. A.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Crenolanib and intensive chemotherapy in adults with newly diagnosed FLT3-mutated AML
    Journal Article

    Wang, E. S.; Goldberg, A. D.; Tallman, M.; Walter, R. B.; Karanes, C.; Sandhu, K.; Vigil, C. E.; Collins, R.; Jain, V.; Stone, R. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • NTRK gene fusion testing and management in lung cancer
    Review

    Repetto, M.; Chiara Garassino, M.; Loong, H. H.; Lopez-Rios, F.; Mok, T.; Peters, S.; Planchard, D.; Popat, S.; Rudzinski, E. R.; Drilon, A.; more...
    Cancer Treatment Reviews (2024)

    Fulltext@MSK | Save
  • Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: Tips and notes for effective use in clinical practice
    Review

    Ohmoto, A.; Fuji, S.
    Expert Review of Anti-Infective Therapy (2024)

    Fulltext@MSK | Save
  • Prolonged gastrointestinal manifestations after recovery from COVID-19
    Journal Article

    Elmunzer, B. J.; Palsson, O. S.; Forbes, N.; Zakaria, A.; Davis, C.; Canakis, A.; Qayed, E.; Bick, B.; Pawa, S.; Tierney, W. M.; more...
    Clinical Gastroenterology and Hepatology (2024)

    Fulltext@MSK | Save